Cannae (CNNE) director awarded 7,818 restricted shares; 32,753 owned
Cannae Holdings (CNNE) reported a director equity grant.
Rhea-AI Filing Summary
Cannae Holdings (CNNE) reported a director equity grant. On 11/12/2025, a director acquired 7,818 shares of common stock at $0, reflecting a restricted stock award. Following the transaction, beneficial ownership stood at 32,753 shares, held directly.
The award vests in three equal annual installments beginning 11/12/2026, aligning compensation with multi‑year service. This filing documents insider equity compensation rather than an open‑market purchase.
Positive
- None.
Negative
- None.
Insights
Routine director RS grant: 7,818 shares, three-year vesting.
The filing records a restricted stock grant of 7,818 shares at $0 on 11/12/2025, increasing direct beneficial ownership to 32,753 shares. This indicates non-cash compensation rather than a market transaction.
The award vests in three equal annual tranches beginning 11/12/2026, creating service-based retention. Actual realized value depends on future share price and continued service through vest dates.
This is a standard governance practice for board compensation and does not, by itself, change the company’s outlook.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,818 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock vesting in three equal annual installments beginning November 12, 2026.
FAQ
What did Cannae Holdings (CNNE) disclose in this Form 4?
What is the vesting schedule for the CNNE restricted stock?
Was this an open-market purchase of CNNE stock?
What is the reporting person’s relationship to Cannae Holdings (CNNE)?
How is ownership reported for this CNNE Form 4 transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.